PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute Cleveland Clinic, Cleveland, Ohio, USA.\', \'Department of Pulmonary Medicine, Respiratory Institute, Cleveland, Ohio, USA.\', \'C5 Research, Cleveland Clinic, Cleveland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/clc.23451
?:doi
?:hasPublicationType
?:journal
  • Clinical cardiology
is ?:pmid of
?:pmid
?:pmid
  • 32830894
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.42
?:rankingScore_hIndex
  • 65
is ?:relation_isRelatedTo_publication of
?:title
  • Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all